Enzychem Lifesciences Corporation (183490.KQ)
KRW 1329.0
(-2.71%)
KRW 1329.0
(-2.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.25 Billion | -14.31 Billion | -18.58 Billion | -14.02 Billion | -15.09 Billion | -13.52 Billion |
| Net Income | -9.32 Billion | -25.09 Billion | -27.86 Billion | -17.5 Billion | -16.87 Billion | -14.42 Billion |
| Depreciation & Amortization | 3.51 Billion | 2.38 Billion | 2.11 Billion | 2.03 Billion | 1.94 Billion | 1.53 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 54.33 Million | -306.11 Million | 711.9 Million | 50.34 Million | - | - |
| Change in working capital | -6.5 Billion | -3.21 Billion | -1.73 Billion | 2.14 Billion | -592.32 Million | -465.28 Million |
| Other non-cash items | 13.35 Billion | 19.32 Billion | 11.66 Billion | 1.93 Billion | 4.55 Billion | 3.74 Billion |
| Investing Cash Flow | 53.56 Billion | -109.23 Billion | -9.72 Billion | -45.24 Billion | -18.05 Billion | -36.03 Billion |
| Investments in PPE | -2.3 Billion | -8.01 Billion | -5.88 Billion | -3.09 Billion | -2.84 Billion | -3.68 Billion |
| Acquisitions | -577.52 Million | 1.34 Million | 7.5 Million | 1.5 Billion | 43.85 Million | 200 Thousand |
| Investment purchases | -454.93 Billion | -231.12 Billion | -119.82 Billion | -109.48 Billion | -41.91 Billion | -45.4 Billion |
| Sales/Maturities of investments | 517.28 Billion | 137.75 Billion | 116.15 Billion | 66.91 Billion | 26.8 Billion | 13.75 Billion |
| Other Investing Activities | -5.9 Billion | -7.85 Billion | -188.23 Million | 424.1 Million | -151.27 Million | -703.19 Million |
| Financing Cash Flow | -35.5 Billion | 128.5 Billion | 29.26 Billion | 58.82 Billion | 30.9 Billion | 47.23 Billion |
| Debt repayment | -34.85 Billion | -24.68 Billion | -338.4 Million | -58.86 Billion | -1.25 Billion | -1.71 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -641.44 Thousand | - | - | - | - | - |
| Common Stock Issuance | - | 153.71 Billion | 30.1 Billion | 224.89 Million | 32.81 Billion | 48.94 Billion |
| Other Financing Activities | -555.13 Thousand | -230.00 | 29.81 Billion | -22.96 Million | -418.62 Million | 2.02 Million |
| Accounts receivables | -4.08 Billion | -1.17 Billion | -1.06 Billion | 4.64 Billion | -1.26 Billion | 3.01 Billion |
| Accounts payables | 4.39 Billion | -333.71 Million | 1.7 Billion | -1.87 Billion | 1.75 Billion | -3.69 Billion |
| Inventory | -4.57 Billion | -1.43 Billion | 822.73 Million | -1.33 Billion | -719.26 Million | -174.73 Million |
| Other working capital | -2.23 Billion | -258.18 Million | -3.2 Billion | 701.47 Million | -359.06 Million | 381.76 Million |
| Cash at beginning of period | 7.68 Billion | 2.78 Billion | 1.85 Billion | 2.28 Billion | 3.6 Billion | 5.3 Billion |
| Cash at end of period | 15.47 Billion | 7.68 Billion | 2.78 Billion | 1.85 Billion | 2.28 Billion | 3.6 Billion |
| Capital Expenditure | -2.3 Billion | -8.01 Billion | -5.88 Billion | -3.09 Billion | -2.84 Billion | -3.68 Billion |
| Effect of forex changes on cash | -13.79 Million | -83.11 Million | 12.7 Million | -12.05 Million | 14.36 Million | 4.5 Million |
| Net cash flow / Change in cash | 7.78 Billion | 4.89 Billion | 926.54 Million | -430.15 Million | -1.31 Billion | -1.7 Billion |
| Free Cash Flow | -12.56 Billion | -22.33 Billion | -24.47 Billion | -17.11 Billion | -17.93 Billion | -17.2 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.36 Billion | -1.08 Billion | -1.83 Billion | -9.32 Billion | -2.63 Billion | -2.45 Billion |
| Depreciation & Amortization | 878.09 Million | 895.08 Million | 817.64 Million | 3.51 Billion | 909.58 Million | 958.93 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | -10.00 | 54.33 Million | - | - |
| Change in working capital | 307.63 Million | -2.85 Billion | -170.51 Million | -6.5 Billion | -1.17 Billion | -2.68 Billion |
| Other non-cash items | 2.61 Billion | 5.06 Billion | 323.61 Million | 13.35 Billion | 3.55 Billion | 5.24 Billion |
| Investing Cash Flow | -2.69 Billion | 5.85 Billion | 13.92 Billion | 53.56 Billion | -511.35 Million | 12.67 Billion |
| Investments in PPE | -241.89 Million | -50.59 Million | -543.03 Million | -2.3 Billion | -872.21 Million | -109.43 Million |
| Acquisitions | - | - | - | -577.52 Million | - | - |
| Investment purchases | -32.66 Billion | -85.61 Billion | -36.38 Billion | -454.93 Billion | -140.53 Billion | -134.67 Billion |
| Sales/Maturities of investments | 30.58 Billion | 98.56 Billion | 54.43 Billion | 517.28 Billion | 143.5 Billion | 147.54 Billion |
| Other Investing Activities | -379.26 Million | -7.04 Billion | -3.58 Billion | -5.9 Billion | -2.6 Billion | -84.31 Million |
| Financing Cash Flow | -9.46 Billion | -641.76 Million | -1.07 Billion | -35.5 Billion | -348.45 Million | -4.08 Billion |
| Debt repayment | -722.76 Million | -469.16 Million | -902.98 Million | -34.85 Billion | -920.33 Million | -3.17 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -8.55 Billion | - | - | -641.44 Thousand | 750 Million | -750 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -181.8 Million | -120 Million | -641.27 Thousand | -555.13 Thousand | -10.00 | -555.13 Thousand |
| Accounts receivables | 809.91 Million | -597.37 Million | 1.3 Billion | -4.08 Billion | -4.48 Billion | -2.06 Billion |
| Accounts payables | -411.73 Million | -1.57 Billion | -302.5 Million | 4.39 Billion | 3.71 Billion | 198.25 Million |
| Inventory | 151.63 Million | -399.28 Million | -544.73 Million | -4.57 Billion | -629.94 Million | -1.15 Billion |
| Other working capital | -242.18 Million | -275.88 Million | -629.81 Million | -2.23 Billion | 220.98 Million | 335.22 Million |
| Cash at beginning of period | 18.35 Billion | 15.47 Billion | 4.67 Billion | 7.68 Billion | 8.1 Billion | 3.37 Billion |
| Cash at end of period | 5.45 Billion | 18.35 Billion | 15.47 Billion | 15.47 Billion | 4.67 Billion | 8.1 Billion |
| Capital Expenditure | -241.89 Million | -50.59 Million | -543.03 Million | -2.3 Billion | -872.21 Million | -109.43 Million |
| Effect of forex changes on cash | - | 9.6 Million | -22.06 Million | -13.79 Million | -7.05 Million | 9.11 Million |
| Net cash flow / Change in cash | -12.89 Billion | 2.88 Billion | 10.79 Billion | 7.78 Billion | -3.42 Billion | 4.73 Billion |
| Free Cash Flow | -1 Billion | -2.39 Billion | -2.58 Billion | -12.56 Billion | -3.43 Billion | -3.98 Billion |
OBIO
MDPR
DIANATEA
CZT
PX
SABTNL